ATE399778T1 - Glucopyranosid, verfahren zu deren isolierung, pharmazeutische zusammensetzung und verwendung davon - Google Patents

Glucopyranosid, verfahren zu deren isolierung, pharmazeutische zusammensetzung und verwendung davon

Info

Publication number
ATE399778T1
ATE399778T1 AT02714415T AT02714415T ATE399778T1 AT E399778 T1 ATE399778 T1 AT E399778T1 AT 02714415 T AT02714415 T AT 02714415T AT 02714415 T AT02714415 T AT 02714415T AT E399778 T1 ATE399778 T1 AT E399778T1
Authority
AT
Austria
Prior art keywords
glucopyranoside
isolation
pharmaceutical composition
hydroxybenzylbenzofuran
beta
Prior art date
Application number
AT02714415T
Other languages
English (en)
Inventor
Rakesh Maurya
Deepa Singh
Asha Bhagat
Om Gupta
Sukhdev Handa
Original Assignee
Council Scient Ind Res
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Council Scient Ind Res filed Critical Council Scient Ind Res
Application granted granted Critical
Publication of ATE399778T1 publication Critical patent/ATE399778T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H7/00—Compounds containing non-saccharide radicals linked to saccharide radicals by a carbon-to-carbon bond
    • C07H7/06—Heterocyclic radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Saccharide Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
AT02714415T 2002-04-08 2002-04-08 Glucopyranosid, verfahren zu deren isolierung, pharmazeutische zusammensetzung und verwendung davon ATE399778T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/IN2002/000105 WO2003087093A1 (en) 2002-04-08 2002-04-08 Novel glucopyranoside, process for isolation thereof, pharmaceutical composition containing same and use thereof

Publications (1)

Publication Number Publication Date
ATE399778T1 true ATE399778T1 (de) 2008-07-15

Family

ID=29227416

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02714415T ATE399778T1 (de) 2002-04-08 2002-04-08 Glucopyranosid, verfahren zu deren isolierung, pharmazeutische zusammensetzung und verwendung davon

Country Status (7)

Country Link
EP (1) EP1495019B1 (de)
JP (1) JP4309769B2 (de)
CN (1) CN1280290C (de)
AT (1) ATE399778T1 (de)
AU (1) AU2002246317A1 (de)
DE (1) DE60227421D1 (de)
WO (1) WO2003087093A1 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI310033B (en) * 2003-03-14 2009-05-21 Yamanouchi Pharma Co Ltd C-glycoside derivatives or salts thereof
CA2549022A1 (en) 2003-08-01 2005-02-10 Janssen Pharmaceutica N.V. Substituted benzimidazole-, benztriazole-, and benzimidazolone-o-glucosides
RS20060320A (en) 2003-08-01 2008-08-07 Janssen Pharmaceutica N.V., Substituted indazole-o-glucosides
WO2005012318A2 (en) 2003-08-01 2005-02-10 Janssen Pharmaceutica Nv Substituted fused heterocyclic c-glycosides
CA2549025A1 (en) 2003-08-01 2005-02-10 Janssen Pharmaceutica N.V. Substituted indole-o-glucosides
AU2005219779B2 (en) 2004-03-04 2011-04-14 Kissei Pharmaceutical Co., Ltd. Fused heterocycle derivative, medicinal composition containing the same, and medicinal use thereof
WO2005085265A1 (ja) * 2004-03-04 2005-09-15 Kissei Pharmaceutical Co., Ltd. 縮合ヘテロ環誘導体、それを含有する医薬組成物およびその医薬用途
EP2105442A4 (de) 2006-12-21 2013-01-23 Astellas Pharma Inc Verfahren zur herstellung eines c-glykosidderivats und synthetisches zwischenprodukt dafür
TW201623321A (zh) 2014-05-13 2016-07-01 韓美藥品股份有限公司 雙環衍生物及包含其之藥學組成物
CN106674311B (zh) * 2016-12-27 2019-02-05 西安交通大学 一种苯并呋喃苷类化合物及其制备方法和应用

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6627611B2 (en) * 2000-02-02 2003-09-30 Kotobuki Pharmaceutical Co Ltd C-glycosides and preparation of thereof as antidiabetic agents

Also Published As

Publication number Publication date
JP2005528398A (ja) 2005-09-22
DE60227421D1 (de) 2008-08-14
WO2003087093A1 (en) 2003-10-23
EP1495019A1 (de) 2005-01-12
AU2002246317A1 (en) 2003-10-27
JP4309769B2 (ja) 2009-08-05
EP1495019B1 (de) 2008-07-02
CN1280290C (zh) 2006-10-18
CN1633432A (zh) 2005-06-29

Similar Documents

Publication Publication Date Title
WO2004037181A3 (en) Glycinenitrile-based inhibitors of dipeptidyl peptidase iv and methods
PT958296E (pt) Compostos heterociclicos processo para a sua preparacao composicoes farmaceuticas contendo-os e sua utilizacao no tratamento da diabetes e doencas relacionadas
ATE396190T1 (de) Substituierte heteroarylalkansäure und ihre verwendung als inhibitoren der aldose reductase
ATE448225T1 (de) Aza-bicycloalkylether und deren verwendung als alpha7-nachr agonisten
BR0309546A (pt) Composto, composição farmacêutica que compreende o mesmo, processo para a sua preparação e utilização e método para tratamento profilático ou terapêutico de diabetes do tipo ii
DE60315323D1 (de) Piperidinderivate zur verwendung bei der behandlung von durch chemokins vermittelten leiden
NO20054787L (no) Indenderivater som farmasotiske midler
ATE534656T1 (de) Neue oligosaccharide, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzungen
DE50011034D1 (de) N-substituierte 4-aminopteridine, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
ATE399778T1 (de) Glucopyranosid, verfahren zu deren isolierung, pharmazeutische zusammensetzung und verwendung davon
SE9804212D0 (sv) Compounds
AU2001246999A1 (en) New neurokinin antagonists for use as medicaments
ATE454383T1 (de) Neue verbindungen, deren verwendung und herstellung
DE60206068D1 (de) Aralkyltetrahydropyridine, deren herstellung und pharmazeutische zusammensetzungen, die diese enthalten
WO2003080631A3 (en) Plasma carboxypeptidase b inhibitors
WO2002072567A3 (en) Heterocyclic compounds, process for their preparation and pharmaceutical compositions containing them
DE69917668D1 (de) Substanz gm-95, verfahren zu ihrer herstellung und ihre verwendung
BR9610175A (pt) Composto processo de preparação do composto composição farmacêutica e utilização do composto
DE69619868T2 (de) Piperazinylalkylthiopyrimidin derivate, diese enthaltende pharmazeutische zusammensetzungen und verfahren zu deren herstellung
ATE308513T1 (de) Naphthamid-neurokinin antagonisten zur verwendung als medikamente
ATE365162T1 (de) Tetrahydropyridyl-alkyl-heterozykle, verfahren zu ihrer herstellung und pharmazeutische zusammensetzungen die sie enthalten
ATE358675T1 (de) Stabiles lansoprazol, enthaltend mehr als 500 ppm bis zu 3000 ppm wasser und mehr als 200 ppm bis zu 5000 ppm alkohol
AU2002212241A1 (en) Method for producing chiral compounds
EA200100156A3 (ru) Новые производные 6-сульфамоил-3-хинолилфосфоновой кислоты, способ их получения и содержащие их фармацевтические композиции
BR9805535A (pt) Novos compostos heterocìclicos, um processo para a sua preparação e composições farmacêuticas contendo os mesmos.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties